cbdMD, Inc. to Host Conference Call to Discuss September 30, 2025, Fourth Quarter and Fiscal Year 2025 Results
Rhea-AI Summary
cbdMD (NYSE American: YCBD) will host a conference call on Friday, December 19, 2025 at 4:20 p.m. ET to discuss its September 30, 2025 fourth quarter and fiscal year 2025 financial results and business progress.
Investors in the USA/Canada can join by phone at 888-880-3330. A live webcast and replay are available via the provided link and will remain accessible through December 19, 2026.
Positive
- None.
Negative
- None.
News Market Reaction 40 Alerts
On the day this news was published, YCBD gained 58.74%, reflecting a significant positive market reaction. Argus tracked a peak move of +54.5% during that session. Our momentum scanner triggered 40 alerts that day, indicating elevated trading interest and price volatility. This price movement added approximately $8M to the company's valuation, bringing the market cap to $23M at that time. Trading volume was exceptionally heavy at 7.3x the daily average, suggesting very strong buying interest.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus 3 Up
YCBD gained 58.74% with elevated volume, while key peers showed mixed moves: CPHI -6.62%, SBFM -0.7%, SNOA +5.03%, BFRI -6.36%, EVOK +0.18%. Momentum scanner peers (BFRI, INM, IMCC) were all moving up, highlighting YCBD’s move as stock-specific rather than sector-driven.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Dec 08 | Listing compliance update | Positive | +4.7% | Regained full compliance with NYSE American listing standards. |
| Dec 08 | Listing compliance update | Positive | +4.7% | Duplicate event noting removal of the “.BC” indicator. |
| Nov 21 | Prelim fiscal 2025 results | Positive | -6.7% | Preliminary results with improved net loss and stable net sales. |
| Nov 21 | Prelim fiscal 2025 results | Positive | -6.7% | Duplicate preliminary results release with same financial trends. |
| Oct 22 | Product expansion | Positive | -5.7% | Expansion of Herbal Oasis THC-infused seltzer lineup with new flavors. |
Stock often shows mixed or negative reactions around operational and product updates, with occasional positive alignment on regulatory milestones.
Over the last few months, cbdMD reported preliminary fiscal 2025 results indicating net sales near prior-year levels but an improved net loss, and expanded its Herbal Oasis THC-infused seltzer line on Oct 22, 2025. The company also regained full compliance with NYSE American listing standards, removing the “.BC” flag on Dec 8, 2025. Today's earnings conference-call announcement follows these operational and listing milestones, continuing a pattern of frequent financial and product updates.
Market Pulse Summary
The stock surged +58.7% in the session following this news. A strong positive reaction aligns with the stock’s elevated pre-call positioning but far exceeds the average 6.44% move seen on prior earnings-conference announcements. With shares up 58.74% and trading above the 200-day MA, past divergence around operational news suggests that post-call details have often reset expectations, which could influence how durable such spikes proved historically.
Key Terms
webcast technical
AI-generated analysis. Not financial advice.
CONFERENCE CALL DETAILS
Friday, December 19, 2025, 4:20 p.m. Eastern Time
Webcast/Webcast Replay link - available through December 19, 2026:
https://app.webinar.net/13voDmbBlxj
About cbdMD, Inc.
cbdMD, Inc. (NYSE American: YCBD) is one of the leading and most highly trusted and most recognized cannabidiol (CBD) brands with a comprehensive line of
(1) THC-free is defined as below the level of detection using validated scientific analytical methods.
Contact Information:
cbdMD, Inc.
Ronan Kennedy, CEO and CFO
Phone: +1 (704) 445-3064
email: IR@cbdmd.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/cbdmd-inc-to-host-conference-call-to-discuss-september-30-2025-fourth-quarter-and-fiscal-year-2025-results-302645275.html
SOURCE cbdMD, Inc.